New Device Technologies Influence Treatment Options and Clinical Trials
Choosing valve repair or replacement for most patients relies on the clinical judgement of their cardiologist and cardiac surgeon based on factors including overall health, the valve in question, and the type/severity of the damage. This paper explores recent developments in heart valve technology and the resulting implications for both medical device sponsors and clinical trials.
- The size of the commercial, global valve replacement market
- Surgical options for patients medically ineligible for open heart surgery
- Compare and contrast TAVR and TAVI procedures and clinical studies
Submit this form for download.